Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts.
Current regimens for induction therapy of pediatric acute lymphoblastic leukemia (ALL), or for re-induction post relapse, use a combination of vincristine (VCR), a glucocorticoid, and L-asparaginase (ASP) with or without an anthracycline. With cure rates now approximately 80%, robust pre-clinical mo...
Saved in:
Main Authors: | Barbara Szymanska, Urszula Wilczynska-Kalak, Min H Kang, Natalia L M Liem, Hernan Carol, Ingrid Boehm, Daniel Groepper, C Patrick Reynolds, Clinton F Stewart, Richard B Lock |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/88670b55056c4fe1b0a9b4f77ad7b243 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
by: Shen Yaqing, et al.
Published: (2021) -
ASSOCIATION OF HYPERDIPLOIDY WITH REMISSION STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AFTER INDUCTION THERAPY
by: Saqib Hussain Korejo, et al.
Published: (2019) -
Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia
by: Xiaoming Liu, et al.
Published: (2021) -
Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
by: Shumaila Sayyab, et al.
Published: (2021) -
Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations.
by: Yan Wang, et al.
Published: (2014)